We are live on
!
Find out more
NL
Navalign LLC Portfolio holdings
AUM
$429M
1-Year Est. Return
18.12%
This Quarter
Est. Return
+2.25%
1 Year Est. Return
+18.12%
3 Year Est. Return
+50.7%
5 Year Est. Return
+57.4%
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$28.4M
(+7.5%)
Cap. Flow
+$21.5M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
52.74%
Holding
512
New
387
Increased
60
Reduced
39
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan US Quality Factor ETF
JQUA
|
+$7.59M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$2.39M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$839K |
| 4 |
First Trust Smith Unconstrained Bond ETF
UCON
|
+$789K |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$750K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$3.86M |
| 2 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$909K |
| 3 |
NVIDIA
NVDA
|
+$367K |
| 4 |
Eli Lilly
LLY
|
+$191K |
| 5 |
Broadcom
AVGO
|
+$188K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.55% |
| 2 | Healthcare | 5.47% |
| 3 | Financials | 4.88% |
| 4 | Communication Services | 3.64% |
| 5 | Industrials | 3.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Norfolk Southern
NSC
$75.1B
| $45.1K | 0.01% |
+156
| New | +$45.1K |
|
202
Elevance Health
ELV
$85.5B
| $44.9K | 0.01% |
+128
| New | +$43.3K |
|
203
Air Products & Chemicals
APD
$67.6B
| $44.8K | 0.01% |
+182
| New | +$46.1K |
|
204
Sempra
SRE
$54.8B
| $43.6K | 0.01% |
+494
| New | +$45K |
|
205
PACCAR
PCAR
$70.1B
| $41.3K | 0.01% |
+377
| New | +$38.6K |
|
206
Ferrari
RACE
$72.5B
| $40.7K | 0.01% |
+110
| New | +$44K |
|
207
Zimmer Biomet
ZBH
$18.4B
| $39.9K | 0.01% |
+444
| New | +$42.1K |
|
208
TSMC
TSM
$2.18T
| $39.2K | 0.01% |
+129
| New | +$37.9K |
|
209
Deere & Co
DE
$168B
| $39.1K | 0.01% |
+84
| New | +$39.4K |
|
210
ARK Innovation ETF
ARKK
$6.29B
| $38.6K | 0.01% |
+502
| New | +$41.6K |
|
211
Vanguard FTSE Europe ETF
VGK
$31.1B
| $38.5K | 0.01% |
+460
| New | +$37.4K |
|
212
Energy Transfer Partners
ET
$69.3B
| $37.5K | 0.01% |
+2,273
| New | +$37.8K |
|
213
Hartford Financial Services
HIG
$39.3B
| $36.6K | 0.01% |
+265
| New | +$35K |
|
214
Robinhood
HOOD
$83.9B
| $36.3K | 0.01% |
+321
| New | +$41.7K |
|
215
Packaging Corp of America
PKG
$22.8B
| $35.7K | 0.01% |
+173
| New | +$35.2K |
|
|
MRSH
216
Marsh
MRSH
$91.5B
| $35.5K | 0.01% |
+191
| New | +$35.7K |
|
217
Travelers Companies
TRV
$80.2B
| $35.1K | 0.01% |
+121
| New | +$34.1K |
|
218
Corteva
CTVA
$51.3B
| $34.8K | 0.01% |
+519
| New | +$33.6K |
|
219
Texas Instruments
TXN
$261B
| $34.5K | 0.01% |
+199
| New | +$34.1K |
|
220
Shopify
SHOP
$195B
| $34.3K | 0.01% |
+213
| New | +$34.2K |
|
221
Vanguard Total International Stock ETF
VXUS
$163B
| $33.6K | 0.01% |
+445
| New | +$33.2K |
|
222
Franco-Nevada
FNV
$46B
| $33.6K | 0.01% |
+162
| New | +$32.9K |
|
223
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$41.4B
| $33K | 0.01% |
+568
| New | +$33K |
|
224
Arm
ARM
$302B
| $32.8K | 0.01% |
+300
| New | +$43.6K |
|
225
Mineralys Therapeutics
MLYS
$2.41B
| $32.7K | 0.01% |
+900
| New | +$36.1K |
|
Similar funds
BP
LJAF
CSNH
OA
RCWVOTCITCONY
MAM
GPGA
WPW
Navalign LLC's Q4 2025 Portfolio in Review
As of Q4 2025, Navalign LLC held 512 positions worth $407M, up 7.5% from $379M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Navalign LLC deployed $21.5M of net new capital in Q4 2025, opening 387 new positions and adding to 60 existing holdings. Its largest new stake was JPMorgan US Quality Factor ETF: 120,844 shares worth $7.63M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $3.86M trimmed.
- Navalign LLC's largest Q4 2025 buy was JPMorgan US Quality Factor ETF: 120,844 shares worth $7.63M.
- Navalign LLC added most to Fidelity Total Bond ETF in Q4 2025, an estimated $2.39M increase.
- Navalign LLC's biggest Q4 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $3.86M.
- Navalign LLC fully exited Cue Biopharma in Q4 2025, selling an estimated $18K.
- Navalign LLC's ten largest holdings make up 53% of its $407M portfolio in Q4 2025.
- Navalign LLC opened 387 new positions and closed 1 in Q4 2025.
- Navalign LLC's portfolio value rose 7.5% quarter-over-quarter to $407M.
Based on Navalign LLC's 13F filing for Q4 2025, filed 5 Feb 2026.